TRANSDERMALES THERAPEUTISCHES SYSTEM

European patent · EP3955901 · In force

Register entry

Publication number
EP3955901
Application number
EP20718679
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 17, 2020
Published
Feb 23, 2022
Granted
May 6, 2026
Protection ends at the latest
Apr 16, 2040
Next annual fee due
Apr 30, 2027
IPC classes
A61K 9/70 (2006.01)
A61K 31/135 (2006.01)
A61P 25/24 (2006.01)
A61P 29/00 (2006.01)
Priority
US 201916386458 17.04.2019
EP 19169726 17.04.2019
PCT application
PCT/EP2020/060903 17.04.2020
PCT publication
WO2020/212596 22.10.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 3, 2026

    Agent entered

    Representative
    Felber & Partner AG, Dufourstrasse 116, 8008 Zürich

    Published in Swissreg on 03.06.2026

  2. May 6, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.05.2026

Parties

Holder

LTS Lohmann Therapie-Systeme AG

Lohmannstrasse 2, 56626 Andernach, DE

Agent

Felber & Partner AG

Dufourstrasse 116, 8008 Zürich

Inventor

HAMMES, Florian

56626 Andernach, DE

KLEUDGEN, Tobias

56729 Ettringen, DE

TOMELERI, Anja

56567 Neuwied, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.